SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 118 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $151,658,000 | +23.7% | 1,554,979 | +17.7% | 0.01% | +11.1% |
| Q4 2014 | $122,569,000 | +37.7% | 1,320,921 | +2.1% | 0.01% | +28.6% |
| Q3 2014 | $89,002,000 | -31.5% | 1,294,021 | +4.3% | 0.01% | -30.0% |
| Q2 2014 | $129,992,000 | +47.3% | 1,240,381 | +16.6% | 0.01% | +42.9% |
| Q1 2014 | $88,251,000 | +42.7% | 1,063,652 | +11.3% | 0.01% | +40.0% |
| Q4 2013 | $61,849,000 | +12.6% | 955,628 | +10.1% | 0.01% | 0.0% |
| Q3 2013 | $54,927,000 | +99.3% | 867,605 | +32.2% | 0.01% | +66.7% |
| Q2 2013 | $27,562,000 | – | 656,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|